23 May 2013
Keywords: wyeth, licenses, vsv, patents, gtx, firm, focuses
Article | 03 February 2003
US firm GTx, which focuses on men's health, has entered into across-license and commercial option agreement with drug major Wyeth ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
3 February 2003
© 2013 thepharmaletter.com